CardioWise Makes FDA Submission With Request for Expedited Approval for COVID-19

This month, CardioWise filed a 510(k) Application for its machine learning-based heart health analysis software known as SQuEEZTM. The software, combined with cardiac computerized tomography (CT) imaging, has the opportunity to become the single most effective way for patients to receive an accurate and early diagnosis of heart disease and the quantitative analysis provides a means for easily monitoring treatment effectiveness. > Read more